Depressive and anxiety symptoms during CGRP-targeted migraine prevention: A systematic review and meta-analysis
Background Migraine is frequently comorbid with depression and anxiety, conditions that amplify disease burden and may impair preventive treatment response. Calcitonin gene-related peptide (CGRP)-targeted therapies have demonstrated robust efficacy in reducing migraine frequency, with emerging evidence suggesting concu...